Stem Cell's Secretome Delivery Systems

Area of Science:

• Regenerative Medicine
• Biomaterials Science
• Drug Delivery Systems

Background:

• Stem cell secretomes contain therapeutic biomolecules.
• Direct administration of secretomes is limited by in vivo instability and degradation.
• Advancements in localized and stabilized delivery systems are crucial for therapeutic efficacy.

Purpose of the Study:

• To discuss clinical obstacles and potential solutions for secretome delivery.
• To characterize various secretome delivery systems and associated devices.
• To explore optimal strategies for secretome delivery in therapeutic applications.

Main Methods:

• Review of existing literature on secretome delivery systems.
• Analysis of physicochemical properties influencing secretome retention and release (e.g., porosity, particle size, viscoelasticity).
• Examination of different dosage forms (hydrogels, scaffolds, coatings) and administration devices (sprayers, inhalers, implants).

Main Results:

• Various delivery systems like hydrogels, scaffolds, and bio-mimetic coatings can stabilize and sustain secretome release.
• Physicochemical properties of delivery systems significantly impact secretome quality, quantity, and therapeutic efficacy.
• Specific delivery strategies are required for different organs and administration routes (e.g., lyophilized for inhalation, lipophilic for blood-brain barrier).

Conclusions:

• Optimal secretome delivery necessitates tailored systems based on the target organ and therapeutic goal.
• Coating, muco-adhesive, and cell-adhesive systems are vital for systemic delivery and preventing metabolism.
• Nano-encapsulation and surface modification enhance delivery to specific organs like the liver and kidney, improving overall therapeutic outcomes.